KCNN4 gene variant is associated with ileal crohn's disease in the Australian and New Zealand population

American Journal of Gastroenterology

Volumn 105, Issue 10, 2010, Pages 2209-2217

  Simms, Lisa A ^a,b   Doecke, James D ^b,c   Roberts, Rebecca L ^d   Fowler, Elizabeth V ^e   Zhao, Zhen Zhen ^b   McGuckin, Michael A ^f,g   Huang, Ning ^a,b   Hayward, Nicholas K ^b   Webb, Penelope M ^b   Whiteman, David C ^b   Cavanaugh, Juleen A ^h   McCallum, Ruth ⁱ   Florin, Timothy H J ^e,f,j   Barclay, Murray L ^d,k   Gearry, Richard B ^d,k   Merriman, Tony R ⁱ   Montgomery, Grant W ^b   Radford Smith, Graham L ^a,b,l  

^a Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f Inflammatory Bowel Disease Team   (Australia)

^g MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^h The Australian National University   (Australia)

ⁱ UNIVERSITY OF OTAGO   (New Zealand)

^j MATER HOSPITAL   (Australia)

^k CHRISTCHURCH HOSPITAL   (New Zealand)

^l ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN;

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; CELL ACTIVATION; CELL SECRETION; CHROMOSOME 19Q; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANETH CELL; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; ALLELE; AUSTRALIA; CHI SQUARE DISTRIBUTION; COLON; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; ILEUM; INFLAMMATION; MIDDLE AGED; NEW ZEALAND; NONPARAMETRIC TEST; PATHOLOGY;

ADULT; ALLELES; AUSTRALIA; CHI-SQUARE DISTRIBUTION; COLON; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; ILEUM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LINKAGE (GENETICS); MALE; MIDDLE AGED; NEW ZEALAND; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; GENETIC LINKAGE;

EID: 77957834845     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.161     Document Type: Article

References (43)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspectsand established and evolving therapies. The Lancet 2007; 369: 1641-57.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-740.
3. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-richrepeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
4. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6. (Pubitemid 32531409)
5. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association definesmore than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-62.
6. Franke A, Balschun T, Karlsen TH et al. Sequence variants in IL10, ARPC2and multiple other loci contribute to ulcerative colitis susceptibility. NatGenet 2008; 40: 1319-23.
7. Fisher SA, Tremelling M, Andersen CA et al. Genetic determinants ofulcerative colitis include the ECM1 locus and five loci implicated in Crohn'sdisease. Nat Genet 2008; 40: 710-2. (Pubitemid 351748865)
8. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan ofnonsynonymous SNPs identifies a susceptibility variant for Crohn diseasein ATG16L1. Nat Genet 2007; 39: 207-11. (Pubitemid 46184351)
9. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy indisease pathogenesis. Nat Genet 2007; 39: 596-604.
10. The Wellcome Trust Case Control Consortium. Genome-wide associationstudy of 14,000 cases of seven common diseases and 3,000 shared controls.Nature 2007; 447: 661-78.
11. Fowler EV, Doecke JD, Simms LA et al. ATG16L1 T300A shows strong associationswith disease subgroups in a large Australian IBD population: furthersupport for significant disease heterogeneity. Am J Gastroenterol 2008; 103: 1-8.
12. Duerr RH, Taylor CJ, Brant SR et al. A genome-wide associationstudy identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-3.
13. Ishii TM, Silvia C, Hirschberg B et al. A human intermediate conductancecalcium-activated potassium channel. Proc Natl Acad Sci USA 1997; 94: 11651-6. (Pubitemid 127650718)
14. Ayabe T, Wulff H, Darmoul D et al. Modulation of mouse Paneth cellalpha-defensin secretion by mIKCa1, a Ca2+-activated, inter mediateconductance potassium channel. J Biological Chem 2002; 277: 3793-800. (Pubitemid 34953254)
15. Podolsky DK. Inflammatory bowel disease. N Eng J Med 2002; 347: 417-29.
16. Logsdon NJ, Kang J, Togo JA et al. A novel gene, hKCa4, encodes thecalcium-activated potassium channel in human T lymphocytes. J BiologicalChem 1997; 272: 32723-6. (Pubitemid 28023600)
17. Elphick DA, Mahida YR. Paneth cells: their role in innate immunity andinflammatory disease. Gut 2005; 54: 1802-9.
18. Chandy KG, Wulff H, Beeton C et al. K+ channels as targets for specificimmunodulation. Trends Pharmacol Sci 2004; 25: 280-9.
19. Ghanshani S, Wulff H, Miller MJ et al. Upregulation of theIKCa1 potassium channel during T-cell activation. J Biol Chem 2000; 275: 37137-49.
20. Elliott JI, Higgins CF. IKCa1 activity is required for cell shrinkage, phosphatidylserinetranslocation and death in T lymphocyte apoptosis. EMBORep 2003; 4: 189-94.
21. Di L, Srivastava S, Zhdanova O et al. Inhibition of the K+ channel KCa3.1ameliorates T cell-mediated colitis. Proc Natl Acad Sci 2010; 107: 1541-6;Early Edition:doi:10.1073/pnas.0910133107
22. van Heel DA, Dechairo BM, Dawson G et al. The IBD6 Crohn's diseaselocus demonstrates complex interactions with CARD15 and IBD5 diseaseassociatedvariants. Hum Mol Genet 2003; 12: 2569-75. (Pubitemid 37304680)
23. Low JH, Williams FA, Yang X et al. Inflammatory bowel disease islinked to 19p13 and associated with ICAM-1. Inflammatory Bowel Dis 2004; 10: 173-81. (Pubitemid 38618244)
24. Stange EF, Travis SPL, Vermeire S et al. European evidence based consenseson the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 (Suppl 1): i1-15. (Pubitemid 43268290)
25. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecularand serological classification of Inflammatory bowel disease: Reportof a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5-36.
26. Palmer JS, Zhao ZZ, Hoekstra C et al. Novel variants in growth differentiationfactor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 2006; 91: 4713-6. (Pubitemid 44833463)
27. Roberts RL, Gearry RB, Hollis-Moffat JE et al. IL23R R381Q and ATG16L1T300A are strongly associated with Crohn's disease in a study of NewZealand Caucasians with Inflammatory bowel disease. Am J Gastroenterol 2007; 102: 2754-61.
28. Roberts RL, Hollis-Moffat JE, Gearry RB et al. Confirmation of associationof IRGM and NCF4 with ileal Crohn's disease in a population-based cohort.Genes Immunity 2008; 9: 561-5.
29. Azmanov DN, Kowalczuk S, Rodgers H et al. Further evidence for allelicheterogeneity in Hartnup disorder. Hum Mut 2008; 29: 1217-21.
30. Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn'sdisease in Canterbury, New Zealand: results of an epidemiologic study.Inflammatory Bowel Dis 2006; 12: 936-43. (Pubitemid 44498282)
31. Zhao ZZ, Nyholt DR, Le L et al. KRAS variation and risk of endometriosis.Mol Hum Reprod 2006; 12: 671-6.
32. Simms LA, Doecke JD, Walsh MD et al. Reduced alpha-defensin expressionis associated with inflammation and not NOD2 mutation status in ilealCrohn's disease. Gut 2008; 57: 903-10.
33. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCRperformance. Mol Aspects of Med 2006; 27: 126-39.
34. Pfaffl MW. A new mathematical model for relative quantification in realtimeRT-PCR. Nucleic Acids Res 2001; 29: 2002-7.
35. Pfaffl MW, Tichopad A, Prgomet C et al. Determination of stable housekeepinggenes, differentially regulated target genes and sample integrity:BestKeeper\Excel-based tool using pair-wise correlations. Biotechnol Lett 2004; 26: 509-15. (Pubitemid 38448421)
36. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualization of LDand haplotype maps. Bioinformatics 2005; 21: 263-5. (Pubitemid 40202029)
37. Nyholt DR. A simple correction for multiple testing for single-nucleotidepolymorphisms in linkage disequilibrium with each other. Am J HumGenet 2004; 74: 765-9.
38. Wilson CL, Ouellette AJ, Satchell DP et al. Regulation of intestinal alphadefensinactivation by the metalloproteinase matrilysin in innate hostdefense. Science 1999; 286: 113-7.
39. Johnson GC, Esposito L, Barratt BJ et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-7. (Pubitemid 32952665)
40. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205. (Pubitemid 28307304)
41. Schreiber S, MacDermott RP, Raedler A et al. Increased activation ofisolated intestinal lamina propria mononuclear cells in Inflammatory boweldisease. Gastroenterology 1991; 101: 1020-30.
42. Boirivant M, Marini M, Di Felice G et al. Lamina propria T cells in Crohn'sdisease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557-65. (Pubitemid 29106763)
43. Janossy G, Bofill M, Rowe D et al. The tissue distribution of T lymphocytesexpressing different CD45 polypeptides. Immunology 1989; 66: 517-25. (Pubitemid 19124948)